Notice of Annual General Meeting in Medistim ASA

03 Apr 2023 12:14 CEST

(Oslo, 3rd of April 2023) Medistim ASA (OSE: MEDI), a niche market leader
within ultrasound technology with headquarters in Norway, that develops and
commercializes medical equipment for use within cardiac, vascular and transplant
surgery, announces the Annual General Meeting for the company.

The Annual General Meeting will take place on the 24th of April 2023 at 10.00
and is held at Medistim’s offices at Økernveien 94 in Oslo. Attached are the
agenda for the meeting, the voting form and the annual report for 2022. It is
possible to give proxy with and without voting instructions. By using a proxy
with voting instructions, the shareholders will vote on the specific issues
without personal attendance. For further information on the use of proxy, see
general information at the bottom of the notice and enclosed proxy forms.

Attached is also the annual report for 2022 for Medistim ASA in PDF format and
in ESEF format. The report will also be available on the company web
site: www.medistim.com.

About Medistim:

Medistim was established in 1984, and has a track record of profitable growth
over the past >15 years. The company is a pioneer within its segment, and
continues to invest in new product development. Medistim has wholly owned
subsidiaries with sales organizations in the USA, Canada, China, Germany, UK,
Spain, Denmark
and Norway, in addition to the about 60 distributors in Europe, Asia, Middle
East, Africa, Canada and South America. For more information, visit the Medistim
home page: www.Medistim.com

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act (Verdipapirhandelloven).

For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com

More information:
Access the news on Oslo Bors NewsWeb site

587016_5967007LIEEXZXJOX483-2022-12-31-en.zip
587016_Notice general meeting Medistim ASA 2023.pdf
587016_Annual report Medistim ASA 2022.pdf